Literature DB >> 25745998

The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.

M Sarkar1, V Khare1, K K N Guturi1, N Das1, M K Ghosh1.   

Abstract

Increased abundance of proto-oncogene AKT and reduced expression of tumor suppressor Forkhead box O3 (FOXO3a), the downstream target of AKT, is frequent in carcinogenesis. Mechanistic insights of AKT gene regulation are limited. DEAD box RNA helicase p68 is overexpressed in various cancers and acts as a transcriptional co-activator of several transcription factors, including β-catenin. Here, we report a novel mechanism of p68-mediated transcriptional activation of AKT, and its ensuing effect on FOXO3a, in colon carcinogenesis. Interestingly, we found that the expression of p68 and AKT exhibits strong positive correlation in normal and colon carcinoma patient samples. In addition, p68 increased both AKT messenger RNA (mRNA) and protein, enhanced AKT promoter activity in multiple colon cancer cell lines. Conversely, p68 knockdown led to reduced AKT mRNA and protein, diminished AKT promoter activity. Here, we demonstrated that p68 occupies AKT promoter with β-catenin as well as nuclear factor-κB (NF-κB)and cooperates with these in potentiating AKT transcription. Furthermore, p68 and FOXO3a expression followed inverse correlation in the same set of colon carcinoma samples. We observed that p68 significantly reduced FOXO3a protein level in an AKT-dependent manner. Studies in primary tumors and metastatic lung nodules generated in mice colorectal allograft model, using syngeneic cells stably expressing p68, corroborated our in vitro findings. Hence, a new mechanism of oncogenesis is attributed to p68 by upregulation of AKT and consequent nuclear exclusion and degradation of tumor suppressor FOXO3a.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25745998     DOI: 10.1038/onc.2015.42

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression.

Authors:  Junxia Zhang; Kai Huang; Zhendong Shi; Jian Zou; Yingyi Wang; Zhifan Jia; Anling Zhang; Lei Han; Xiao Yue; Ning Liu; Tao Jiang; Yongping You; Peiyu Pu; Chunsheng Kang
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.

Authors:  Hemant K Roy; Bola F Olusola; Dahn L Clemens; William J Karolski; Anne Ratashak; Henry T Lynch; Thomas C Smyrk
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

3.  Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

Authors:  Sara M Johnson; Pat Gulhati; Bill A Rampy; Yimei Han; Piotr G Rychahou; Hung Q Doan; Heidi L Weiss; B Mark Evers
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

4.  Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation.

Authors:  Kajsa Ericson; Christine Gan; Ian Cheong; Carlo Rago; Yardena Samuels; Victor E Velculescu; Kenneth W Kinzler; David L Huso; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-20       Impact factor: 11.205

5.  Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.

Authors:  Kei Sakamoto; Shin Maeda; Yohko Hikiba; Hayato Nakagawa; Yoku Hayakawa; Wataru Shibata; Ayako Yanai; Keiji Ogura; Masao Omata
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

Review 6.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

7.  Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.

Authors:  Tapashi Mandal; Arijit Bhowmik; Anirban Chatterjee; Uttara Chatterjee; Sandip Chatterjee; Mrinal Kanti Ghosh
Journal:  Cell Signal       Date:  2014-04-12       Impact factor: 4.315

Review 8.  The FoxO code.

Authors:  D R Calnan; A Brunet
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

9.  FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role.

Authors:  M D Bullock; A Bruce; R Sreekumar; N Curtis; T Cheung; I Reading; J N Primrose; C Ottensmeier; G K Packham; G Thomas; A H Mirnezami
Journal:  Br J Cancer       Date:  2013-07-04       Impact factor: 7.640

10.  p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation.

Authors:  Bi-He Cai; Pei-Ching Hsu; I-Lun Hsin; Chung-Faye Chao; Mei-Hua Lu; Hwang-Chi Lin; Shih-Hwa Chiou; Pao-Luh Tao; Jang-Yi Chen
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

View more
  19 in total

Review 1.  The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.

Authors:  Mohamed A M Ali
Journal:  Int J Clin Oncol       Date:  2021-03-03       Impact factor: 3.402

Review 2.  Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.

Authors:  Hui Xu; Lei Liu; Weilin Li; Duowu Zou; Jun Yu; Lifu Wang; Chi Chun Wong
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

3.  USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

Authors:  Gouranga Saha; Sibani Sarkar; Partha S Mohanta; Krishna Kumar; Saikat Chakrabarti; Malini Basu; Mrinal K Ghosh
Journal:  Oncogene       Date:  2022-10-15       Impact factor: 8.756

4.  The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.

Authors:  M Sarkar; V Khare; M K Ghosh
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

5.  Solasodine inhibits human colorectal cancer cells through suppression of the AKT/glycogen synthase kinase-3β/β-catenin pathway.

Authors:  Yu-Wen Zhuang; Cun-En Wu; Jin-Yong Zhou; Xu Chen; Jian Wu; Shan Jiang; Hai-Yan Peng; Xi Zou; Jia-Yun Liu; Da-Peng Wu; Tao Gong; Ming-Hao Qi; Tian Xue; Shen-Lin Liu; Hui Cai
Journal:  Cancer Sci       Date:  2017-09-14       Impact factor: 6.716

6.  DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway.

Authors:  Cheng Du; Dan-Qi Li; Na Li; Li Chen; Shi-Sen Li; Yang Yang; Ming-Xiao Hou; Man-Jiang Xie; Zhen-Dong Zheng
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

7.  Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.

Authors:  Fanni Li; Xiwen Dong; Peng Lin; Jianli Jiang
Journal:  Int J Mol Sci       Date:  2018-01-23       Impact factor: 5.923

8.  Long non-coding RNA MIAT promotes gastric cancer growth and metastasis through regulation of miR-141/DDX5 pathway.

Authors:  Min Sha; Mei Lin; Jia Wang; Jun Ye; Jie Xu; Ning Xu; Junxing Huang
Journal:  J Exp Clin Cancer Res       Date:  2018-03-14

9.  Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3'-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression.

Authors:  Arijit Bhowmik; Sayak Chakravarti; Aparajita Ghosh; Rajni Shaw; Suman Bhandary; Satyaranjan Bhattacharyya; Parimal C Sen; Mrinal K Ghosh
Journal:  Oncotarget       Date:  2017-06-27

10.  O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5.

Authors:  Nan Wu; Mingzuo Jiang; Yuying Han; Haiming Liu; Yi Chu; Hao Liu; Jiayi Cao; Qiuqiu Hou; Yu Zhao; Bing Xu; Xin Xie
Journal:  J Cell Mol Med       Date:  2018-11-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.